ABEO•benzinga•
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
Summary
FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga